Wael Abdallah
Group Chief Investment Officer
Biography
Wael Abdallah is the Group Chief Investment Officer for Cambridge Medical & Rehabilitation Center.
Prior to joining Cambridge Medical & Rehabilitation Center team, he was appointed at Amanat Holding PJSC ("Amanat") as a Director in the Investment team with the objective of leading buy-side and sell-side transactions, as well as driving value creation through portfolio management of existing assets.
Mr. Wael served as a Principal at TVM Capital Healthcare Partners (“TVM”), supporting on fundraising, sourcing, and screening new deals (buy-side), exit strategies (sell-side) as well as assisting the finance functions of TVM’s portfolio companies on ad-hoc financial budgeting and planning exercises.
Prior to that, Mr. Wael spent more than seven years with Ernst & Young (“EY”) – Dubai Office, of which approximately six years in EY’s Transaction Advisory Services practice. His last designation at EY was Senior Manager leading buy and sell-side financial and commercial due diligence, business valuations and financial modelling engagements for predominantly clients within the real estate sector in the MENA region. Additionally, Mr. Wael played a key role on multiple M&A transactions for listed companies on DFM and ADX as well as having supported on proposed IPO listings for UAE entities on LSE.
Mr. Wael initially joined EY in 2007 as Team Leader in their Financial Services Risk Management practice after having served for five years in the Corporate Risk Management Department of Bank Audi.
He holds a BBA from the American University of Beirut.
